Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

Nature Medicine

Volumn 2, Issue 12, 1996, Pages 1367-1370

  Gimmi, Claude D ^a   Morrison, Briggs W ^a   Mainprice, Brigitte A ^a   Grieben, John G ^a   Boussiotis, Vassiliki A ^a   Freeman, Gordon J ^a   Park, Suun Young Lee ^a   Watanabe, Michiaki ^a,b   Gong, Jianlin ^a,b   Hayes, Daniel F ^a,b   Kufe, Donald W ^a,b   Nadler, Lee M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL LINE; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY;

3T3 CELLS; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA; FEMALE; FIBROBLASTS; HLA-DR7 ANTIGEN; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MITOGENS; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 16144363002     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1296-1367     Document Type: Article

References (20)

1. van de Bruggen, P. et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254, 1643-1647 (1991).
2. Schlichtholz, B., Legros, Y. & Gillet, D. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res. 52, 6380-6384 (1992).
3. Jung, V. et al. Expression and reconstitution of a biologically active human interferon-gamma receptor in hamster cells. J. Biol. Chem. 265, 1827-1830 (1990).
4. Disis, M.L. et al. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res. 54, 16-20 (1994).
5. Barnd, D.L., Lan, M.S., Metzgar, R.S. & Finn, O.J. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl. Acad. Sci. USA 86, 7159-7163 (1989).
6. Jerome, K.R. et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res. 51, 2908-2916 (1991).
7. Gendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J. & Burchell, J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem. 263, 12820-12823 (1988).
8. Siddiqui, J. et al. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Natl. Acad. Sci. USA 85, 2320-2323 (1988).
9. Wesseling, J., van der Valk, S. & Hilkens, J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol. Cell 7, 565-577 (1996).
10. Ligtenberg, M., Buijs, F., Vos, H. & Hilkens, J. Suppression of cellular aggregation by high levels of episialin. Cancer Res. 52, 2318-2324 (1992).
11. van de Wiel-van Kemenade, E. et al. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J. Immunol. 151, 767-776 (1993).
12. Girling, A. et al. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer 43, 1072-1076 (1989).
13. Hull, S. et al. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun. 1, 261-267 (1989).
14. Kotera, Y., Fontenot, J.D., Pecher, G., Metzgar, R.S. & Finn, O.J. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res. 54, 2856-2860 (1994).
15. McKolanis, J., Pecher, G., Lotze, M. & Finn, O. Mucin reactive CFL induced by in vivo immunization [Abstr.]. Proc. Am. Assoc. Cancer Res. 87, 3144 (1996).
16. Boussiotis, V.A., Freeman, G.J., Gray, G.S., Gribben, J.G. & Nadler, L.M. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J. Exp. Med. 178, 1753-1763 (1993).
17. Dranoff, G. et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543 (1993).
18. Gimmi, C.D. et al. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88, 6575-6579 (1991).
19. Hayes, D.F., Silberstein, D.S., Rodrigue, S. & Kufe, D.W. DF3 antigen, a human epithelial cell mucin, inhibits adhesion of eosinophils to antibody-coated targets. J. Immunol. 145, 962-970 (1990).
20. Kufe, D.W. et al. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3, 223-232 (1984).